Results 181 to 189 of about 22,586,581 (189)

The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma

New England Journal of Medicine, 2002
Jan Delabie, German Ott, Harald Holte
exaly  

Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma

New England Journal of Medicine, 2018
Jan Delabie, Daniel J. Hodson, Stefania Pittaluga   +2 more
exaly  

Two sides of the medallion: poor treatment tolerance but better survival by standard chemotherapy in elderly patients with advanced-stage diffuse large B-cell lymphoma

Annals of Oncology, 2012
J W W Coebergh, M L G Janssen-Heijnen, H C Schouten   +2 more
exaly  

Peripheral blood natural killer cell count is associated with clinical outcome in patients with aaIPI 2–3 diffuse large B-cell lymphoma

Annals of Oncology, 2007
Jean-Philippe JAIS, Myriam Labalette, Jean-François Emile   +2 more
exaly  

CD5-positive diffuse large B-cell lymphoma: a retrospective study in 337 patients treated by chemotherapy with or without rituximab

Annals of Oncology, 2011
Toshiaki Yujiri, Yoshitoyo Kagami, Yukio Kobayashi   +2 more
exaly  

Diffuse large B-cell lymphoma—treatment approaches in the molecular era

Nature Reviews Clinical Oncology, 2013
Louis M Staudt, Mark Roschewski
exaly  

Diffuse large cell lymphoma

Atlas of Genetics and Cytogenetics in Oncology and Haematology, 2011
A Cuneo, Gl Castoldi
exaly  

Diffuse Large B-Cell Lymphoma Subtypes

2013
Faramarz Naeim, P. Nagesh Rao, Sophie X. Song, Ryan T. Phan   +3 more
openaire   +1 more source

Therapy of diffuse large B-cell lymphomas

European Journal of Cancer, 2009
openaire   +2 more sources